Selected research
Industry Growth & Trends
Global AI Pathology Software Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global AI Pathology Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for AI Pathology Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for AI Pathology Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI Pathology Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the AI Pathology Software market include Aiforia Technologies Plc, Ibex Medical Analytics Ltd., Proscia Inc., Philips, Roche Diagnostics International Ltd, Leica Biosystems Nussloch GmbH, Fujifilm Holdings Corporation, Visiopharm A/S and Tempus AI, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global AI Pathology Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The AI Pathology Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AI Pathology Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AI Pathology Software.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global AI Pathology Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
AI Pathology Software Market by Company
Aiforia Technologies Plc
Ibex Medical Analytics Ltd.
Proscia Inc.
Philips
Roche Diagnostics International Ltd
Leica Biosystems Nussloch GmbH
Fujifilm Holdings Corporation
Visiopharm A/S
Tempus AI, Inc.
Yitu Technology Co., Ltd.
Deepwise Healthcare Technology Co., Ltd.
PathAI, Inc.
Paige AI, Inc.
Indica Labs
AI Pathology Software Segment by Type
Histopathology AI Analysis Software
Cytopathology AI Analysis Software
Immunohistochemistry AI Analysis Software
Molecular Pathology AI Analysis Software
AI Pathology Software Segment by Application
Hospital Pathology Department
Third-party Medical Testing Laboratory
Pharmaceutical R&D
AI Pathology Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Pathology Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Pathology Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Pathology Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of AI Pathology Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Histopathology AI Analysis Software
- Cytopathology AI Analysis Software
- Immunohistochemistry AI Analysis Software
- Molecular Pathology AI Analysis Software
Applications
- Hospital Pathology Department
- Third-party Medical Testing Laboratory
- Pharmaceutical R&D
Companies covered
- Aiforia Technologies Plc
- Ibex Medical Analytics Ltd.
- Proscia Inc.
- Philips
- Roche Diagnostics International Ltd
- Leica Biosystems Nussloch GmbH
- Fujifilm Holdings Corporation
- Visiopharm A/S
- Tempus AI, Inc.
- Yitu Technology Co., Ltd.
- Deepwise Healthcare Technology Co., Ltd.
- PathAI, Inc.
- Paige AI, Inc.
- Indica Labs
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global AI Pathology Software Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global AI Pathology Software Market Size by Region (2021-2032)
- 1.4.1 Global AI Pathology Software Market Size by Region (2021-2026)
- 1.4.2 Global AI Pathology Software Market Size by Region (2027-2032)
- 1.5 Key Regions AI Pathology Software Market Size (2021-2032)
- 1.5.1 North America AI Pathology Software Market Size Growth Rate (2021-2032)
- 1.5.2 Europe AI Pathology Software Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific AI Pathology Software Market Size Growth Rate (2021-2032)
- 1.5.4 South America AI Pathology Software Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa AI Pathology Software Market Size Growth Rate (2021-2032)
2 AI Pathology Software Market by Type
- 2.1 Type Introduction
- 2.1.1 Histopathology AI Analysis Software
- 2.1.2 Cytopathology AI Analysis Software
- 2.1.3 Immunohistochemistry AI Analysis Software
- 2.1.4 Molecular Pathology AI Analysis Software
- 2.2 Global AI Pathology Software Market Size by Type
- 2.2.1 Global AI Pathology Software Market Size Overview by Type (2021-2032)
- 2.2.2 Global AI Pathology Software Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global AI Pathology Software Market Size Forecasted by Type (2027-2032)
- 2.3 Global AI Pathology Software Market Size by Regions
- 2.3.1 North America AI Pathology Software Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe AI Pathology Software Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific AI Pathology Software Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America AI Pathology Software Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa AI Pathology Software Market Size Breakdown by Type (2021-2026)
3 AI Pathology Software Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital Pathology Department
- 3.1.2 Third-party Medical Testing Laboratory
- 3.1.3 Pharmaceutical R&D
- 3.2 Global AI Pathology Software Market Size by Application
- 3.2.1 Global AI Pathology Software Market Size Overview by Application (2021-2032)
- 3.2.2 Global AI Pathology Software Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global AI Pathology Software Market Size Forecasted by Application (2027-2032)
- 3.3 Global AI Pathology Software Market Size by Regions
- 3.3.1 North America AI Pathology Software Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe AI Pathology Software Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific AI Pathology Software Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America AI Pathology Software Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa AI Pathology Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 AI Pathology Software Industry Trends
- 4.2 AI Pathology Software Industry Drivers
- 4.3 AI Pathology Software Industry Opportunities and Challenges
- 4.4 AI Pathology Software Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by AI Pathology Software Revenue (2021-2026)
- 5.2 Global AI Pathology Software Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global AI Pathology Software Key Company Headquarters & Area Served
- 5.4 Global AI Pathology Software Company, Product Type & Application
- 5.5 Global AI Pathology Software Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global AI Pathology Software Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 AI Pathology Software Players Market Share by Revenue in 2025
- 5.6.3 2025 AI Pathology Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Aiforia Technologies Plc
- 6.1.1 Aiforia Technologies Plc Company Information
- 6.1.2 Aiforia Technologies Plc Business Overview
- 6.1.3 Aiforia Technologies Plc AI Pathology Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Aiforia Technologies Plc AI Pathology Software Product Portfolio
- 6.1.5 Aiforia Technologies Plc Recent Developments
- 6.2 Ibex Medical Analytics Ltd.
- 6.2.1 Ibex Medical Analytics Ltd. Company Information
- 6.2.2 Ibex Medical Analytics Ltd. Business Overview
- 6.2.3 Ibex Medical Analytics Ltd. AI Pathology Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Ibex Medical Analytics Ltd. AI Pathology Software Product Portfolio
- 6.2.5 Ibex Medical Analytics Ltd. Recent Developments
- 6.3 Proscia Inc.
- 6.3.1 Proscia Inc. Company Information
- 6.3.2 Proscia Inc. Business Overview
- 6.3.3 Proscia Inc. AI Pathology Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Proscia Inc. AI Pathology Software Product Portfolio
- 6.3.5 Proscia Inc. Recent Developments
- 6.4 Philips
- 6.4.1 Philips Company Information
- 6.4.2 Philips Business Overview
- 6.4.3 Philips AI Pathology Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Philips AI Pathology Software Product Portfolio
- 6.4.5 Philips Recent Developments
- 6.5 Roche Diagnostics International Ltd
- 6.5.1 Roche Diagnostics International Ltd Company Information
- 6.5.2 Roche Diagnostics International Ltd Business Overview
- 6.5.3 Roche Diagnostics International Ltd AI Pathology Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Roche Diagnostics International Ltd AI Pathology Software Product Portfolio
- 6.5.5 Roche Diagnostics International Ltd Recent Developments
- 6.6 Leica Biosystems Nussloch GmbH
- 6.6.1 Leica Biosystems Nussloch GmbH Company Information
- 6.6.2 Leica Biosystems Nussloch GmbH Business Overview
- 6.6.3 Leica Biosystems Nussloch GmbH AI Pathology Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Leica Biosystems Nussloch GmbH AI Pathology Software Product Portfolio
- 6.6.5 Leica Biosystems Nussloch GmbH Recent Developments
- 6.7 Fujifilm Holdings Corporation
- 6.7.1 Fujifilm Holdings Corporation Company Information
- 6.7.2 Fujifilm Holdings Corporation Business Overview
- 6.7.3 Fujifilm Holdings Corporation AI Pathology Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Fujifilm Holdings Corporation AI Pathology Software Product Portfolio
- 6.7.5 Fujifilm Holdings Corporation Recent Developments
- 6.8 Visiopharm A/S
- 6.8.1 Visiopharm A/S Company Information
- 6.8.2 Visiopharm A/S Business Overview
- 6.8.3 Visiopharm A/S AI Pathology Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Visiopharm A/S AI Pathology Software Product Portfolio
- 6.8.5 Visiopharm A/S Recent Developments
- 6.9 Tempus AI, Inc.
- 6.9.1 Tempus AI, Inc. Company Information
- 6.9.2 Tempus AI, Inc. Business Overview
- 6.9.3 Tempus AI, Inc. AI Pathology Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Tempus AI, Inc. AI Pathology Software Product Portfolio
- 6.9.5 Tempus AI, Inc. Recent Developments
- 6.10 Yitu Technology Co., Ltd.
- 6.10.1 Yitu Technology Co., Ltd. Company Information
- 6.10.2 Yitu Technology Co., Ltd. Business Overview
- 6.10.3 Yitu Technology Co., Ltd. AI Pathology Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Yitu Technology Co., Ltd. AI Pathology Software Product Portfolio
- 6.10.5 Yitu Technology Co., Ltd. Recent Developments
- 6.11 Deepwise Healthcare Technology Co., Ltd.
- 6.11.1 Deepwise Healthcare Technology Co., Ltd. Company Information
- 6.11.2 Deepwise Healthcare Technology Co., Ltd. Business Overview
- 6.11.3 Deepwise Healthcare Technology Co., Ltd. AI Pathology Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Deepwise Healthcare Technology Co., Ltd. AI Pathology Software Product Portfolio
- 6.11.5 Deepwise Healthcare Technology Co., Ltd. Recent Developments
- 6.12 PathAI, Inc.
- 6.12.1 PathAI, Inc. Company Information
- 6.12.2 PathAI, Inc. Business Overview
- 6.12.3 PathAI, Inc. AI Pathology Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 PathAI, Inc. AI Pathology Software Product Portfolio
- 6.12.5 PathAI, Inc. Recent Developments
- 6.13 Paige AI, Inc.
- 6.13.1 Paige AI, Inc. Company Information
- 6.13.2 Paige AI, Inc. Business Overview
- 6.13.3 Paige AI, Inc. AI Pathology Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Paige AI, Inc. AI Pathology Software Product Portfolio
- 6.13.5 Paige AI, Inc. Recent Developments
- 6.14 Indica Labs
- 6.14.1 Indica Labs Company Information
- 6.14.2 Indica Labs Business Overview
- 6.14.3 Indica Labs AI Pathology Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Indica Labs AI Pathology Software Product Portfolio
- 6.14.5 Indica Labs Recent Developments
7 North America
- 7.1 North America AI Pathology Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America AI Pathology Software Market Size by Country (2021-2026)
- 7.3 North America AI Pathology Software Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe AI Pathology Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe AI Pathology Software Market Size by Country (2021-2026)
- 8.3 Europe AI Pathology Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific AI Pathology Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific AI Pathology Software Market Size by Country (2021-2026)
- 9.3 Asia-Pacific AI Pathology Software Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America AI Pathology Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America AI Pathology Software Market Size by Country (2021-2026)
- 10.3 South America AI Pathology Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa AI Pathology Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa AI Pathology Software Market Size by Country (2021-2026)
- 11.3 Middle East & Africa AI Pathology Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst